SE7714647L - Immunglobulin med reducerad komplementbindning, forfarande for dess framstellning samt medel innehallande sadant immunglobulin - Google Patents

Immunglobulin med reducerad komplementbindning, forfarande for dess framstellning samt medel innehallande sadant immunglobulin

Info

Publication number
SE7714647L
SE7714647L SE7714647A SE7714647A SE7714647L SE 7714647 L SE7714647 L SE 7714647L SE 7714647 A SE7714647 A SE 7714647A SE 7714647 A SE7714647 A SE 7714647A SE 7714647 L SE7714647 L SE 7714647L
Authority
SE
Sweden
Prior art keywords
immunglobulin
procedure
preparation
reduced complement
means containing
Prior art date
Application number
SE7714647A
Other languages
English (en)
Swedish (sv)
Inventor
H Muller
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of SE7714647L publication Critical patent/SE7714647L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
SE7714647A 1976-12-23 1977-12-22 Immunglobulin med reducerad komplementbindning, forfarande for dess framstellning samt medel innehallande sadant immunglobulin SE7714647L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2658334A DE2658334C3 (de) 1976-12-23 1976-12-23 Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
SE7714647L true SE7714647L (sv) 1978-06-24

Family

ID=5996330

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714647A SE7714647L (sv) 1976-12-23 1977-12-22 Immunglobulin med reducerad komplementbindning, forfarande for dess framstellning samt medel innehallande sadant immunglobulin

Country Status (18)

Country Link
US (1) US4160763A (da)
JP (1) JPS5379023A (da)
AT (1) AT359638B (da)
BE (1) BE862290A (da)
BR (1) BR7708559A (da)
CA (1) CA1105383A (da)
CH (1) CH639394A5 (da)
DE (1) DE2658334C3 (da)
DK (1) DK151610C (da)
ES (1) ES465180A1 (da)
FR (1) FR2375247A1 (da)
GB (1) GB1598080A (da)
IL (1) IL53670A (da)
IN (1) IN146967B (da)
MX (1) MX4329E (da)
NL (1) NL190473C (da)
PT (1) PT67436B (da)
SE (1) SE7714647L (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
DE2853453A1 (de) * 1978-12-11 1980-06-19 Behringwerke Ag Mittel zur therapie von immunkomplexerkrankungen
CA1153695A (en) * 1979-08-30 1983-09-13 Syoji Ono S-sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
US4442032A (en) * 1980-12-04 1984-04-10 Lilly Industries Limited Isothiocyanato-azobenzene-sulfonic, arsonic and substituted-glutamic acid haptens
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4479895A (en) * 1982-05-05 1984-10-30 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US10246485B2 (en) 2013-11-08 2019-04-02 Csl Limited Method to concentrate von willebrand factor or complexes thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
DE2404265C3 (de) * 1974-01-30 1980-05-29 Behringwerke Ag, 3550 Marburg Verfahren zum Abreichen von Immunglobulinen
DE2560155C2 (de) * 1974-03-08 1984-04-26 Teijin Ltd., Osaka Humanimmunglobulin-Derivat
DE2527064C3 (de) * 1975-06-18 1979-11-15 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität
JPS5234918A (en) * 1975-09-06 1977-03-17 Biotest Serum Institut Gmbh Production of gmmaglobulin suitable for dosing into vein
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin

Also Published As

Publication number Publication date
DK151610B (da) 1987-12-21
JPS5379023A (en) 1978-07-13
DK574577A (da) 1978-06-24
AT359638B (de) 1980-11-25
NL190473B (nl) 1993-10-18
NL190473C (nl) 1994-03-16
MX4329E (es) 1982-03-25
PT67436B (de) 1979-09-20
BE862290A (fr) 1978-06-23
CH639394A5 (de) 1983-11-15
IL53670A (en) 1980-10-26
GB1598080A (en) 1981-09-16
BR7708559A (pt) 1978-08-15
DE2658334B2 (de) 1980-06-04
NL7713980A (nl) 1978-06-27
ATA922777A (de) 1980-04-15
DK151610C (da) 1988-06-20
CA1105383A (en) 1981-07-21
PT67436A (de) 1978-01-01
IN146967B (da) 1979-10-20
FR2375247B1 (da) 1980-11-28
DE2658334A1 (de) 1978-06-29
DE2658334C3 (de) 1987-05-07
FR2375247A1 (fr) 1978-07-21
ES465180A1 (es) 1979-01-01
US4160763A (en) 1979-07-10

Similar Documents

Publication Publication Date Title
IT8123700A0 (it) L'applicazione in terapeutica dei derivati del 4,5,6,7-tetraidroisossozolo(5,4-c)piridin-3-olo come miotonolitici.
NO803958L (no) Implanterbar regulator for medikamentinfusjon.
AT369651B (de) Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung enthaltend aryl- bzw. heteroarylessigs[ure- bzw. aryl- bzw. heteroarylpropions[urederivate
NL7607338A (nl) Werkwijze voor de bereiding van 1,4-dihydro- pyrinederivaten met vaatverwijdende en bloed- drukverlagende activiteit.
DD129788A5 (de) Verfahren zur herstellung von 3',3'',5',5''-tetrachlorphenol-3,4,5,6-tetrabromsulfophthalein bzw.3',3''-dibrom-5',5''-dichlorphenol-3,4,5,6-tetrachlorsulfophthalein
SE8402550L (sv) N-substituerade deridvat av moranolin
DE59008404D1 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oder IgA-haltige Immunglobulinpräparate.
NL7603193A (nl) Werkwijze ter bereiding van acyclische, alicycli- sche en aromatische n-gesubstitueerde halogeen-2- -pyrrolidinonen met herbicidewerking alsmede her- bicidepreparaten die deze verbindingen als actie- ve component bevatten.
ATA395576A (de) Verfahren zur herstellung von nicht mehr antikomplementaer wirksamen nativ-human- -immunglobulin zur intravenoesen verabreichung mit natuerlicher halbwertszeit
ES8800845A1 (es) Procedimiento para preparar anticuerpos monoclonales y derivados de los mismos
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
IT1067019B (it) Metodo e disposizione per misurare la concentrazione di composti di basso peso molecolare in mezzi complessi in particolare nel trattamento medicale
DK542781A (da) Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf
ES465180A1 (es) Procedimiento para la preparacion de preparados de inmuno- globulinas
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
ATE26213T1 (de) Aeusserlich anzuwendende arzneimittelzubereitung enthaltend adenosin zur behandlung von herpes.
SE7906273L (sv) Sett att framstella en gammaglobulinlosning
DK230580A (da) Sisomicinderivater fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemiddel
NL7612767A (nl) Werkwijze voor de bereiding van ascorbinezuur of een zout daarvan bevattende preparaten.
AU504328B2 (en) Injector for soil treating liquids
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
LU80859A1 (de) Phenylharnstoff-derivate,verfahren zur herstellung dieser verbindungen sowie diese enthaltendes selektives herbizides mittel
AT352883B (de) Verfahren zur herstellung eines pharmazeutisch aktiven amorphen steryl-beta-d-glucosid-esters bzw. von diesen enthaltenden praeparaten
AT307802B (de) Verfahren zur Herstellung von gebrauchsfertigen, pestiziden Zubereitungen
ATA439276A (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praparaten

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7714647-0

Format of ref document f/p: F